Adeno-associated virus (AAV) vectors are the delivery vehicles behind a growing number of gene therapies, and every batch has to be scrutinized with an expanding toolkit of analytical methods before it can reach a patient. These characterization methods measure everything from how many viral genomes are in a vial to whether the capsid shells are actually loaded with the right DNA, and even whether stray host-cell proteins have hitched a ride. No single method covers all the attributes that matter, so manufacturers rely on orthogonal techniques, meaning multiple independent measurements that cross-check each other, to build a complete quality profile.
Counting Genomes With Digital and Quantitative PCR
The most basic question about an AAV batch is how many vector genomes it contains per milliliter. This genome titer drives dosing: give too little and the therapy underperforms, give too much and you risk toxicity. Quantitative PCR (qPCR) has been the standard method for years, but its accuracy depends heavily on how the assay is set up. One head-to-head comparison found that a standard qPCR approach delivered only about 59% accuracy with large run-to-run variability, while an optimized version of the same technique reached roughly 102% accuracy with less than 5% variation between runs, closely matching the results from droplet digital PCR (ddPCR).1PubMed Central. A qPCR Method for AAV Genome Titer with ddPCR-Level of Accuracy and Precision
Droplet digital PCR partitions each reaction into thousands of tiny droplets so that individual DNA molecules are counted in a binary yes-or-no fashion, removing the need for a standard curve. For single-stranded AAV genomes, ddPCR has shown up to four-fold higher titers than a standard qPCR setup, and for self-complementary vectors, the gap can widen to roughly five-fold.2PubMed Central. Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR That does not mean standard qPCR always undercounts by the same margin; the discrepancy depends on primer design, whether the plasmid standard is linearized correctly, and how well the sample is treated before amplification. Reference standard materials endorsed by regulatory agencies exist specifically to anchor these measurements across different labs and prevent drift.3Gene Therapy. Stability of the adeno-associated virus 8 reference standard material One well-documented pitfall involves using a plasmid standard linearized in a way that leaves the inverted terminal repeat (ITR) sequences folded on themselves, artificially inflating genome titers. Cutting the plasmid just outside each ITR eliminates this bias.4Molecular Therapy Methods & Clinical Development. Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR
Distinguishing Full Capsids From Empty Ones
An AAV manufacturing run inevitably produces a mixture of capsids: some carry the intended therapeutic genome, some are empty protein shells, and others contain partial or aberrant DNA fragments. Empty capsids contribute nothing therapeutic but still trigger immune responses, so knowing the ratio of full to empty particles is one of the most scrutinized quality attributes. Several complementary methods tackle this problem from different angles.
Analytical ultracentrifugation (AUC) in sedimentation velocity mode separates capsid species by how fast they move through a spinning solution. Full capsids, being heavier, settle faster and register a sedimentation coefficient near 105 Svedberg units, while empty capsids come in around 66. AUC can also resolve intermediate species that contain partial genomes, something most other methods miss.5PubMed Central. Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors Multiwavelength versions of the technique go a step further: by scanning across multiple UV wavelengths, they can tease apart the protein and DNA contributions to each peak and calculate the protein-to-nucleic-acid ratio for every species in the sample.6PubMed. Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation A comparative study found that while anion-exchange chromatography and UV spectroscopy can quantify empty and filled capsids reasonably well, only sedimentation velocity AUC could reliably identify the low levels of partially filled capsids present in certain preparations.7PubMed. Purity and DNA content of AAV capsids assessed by analytical ultracentrifugation and orthogonal biophysical techniques
AUC is powerful but slow and requires specialized equipment. Mass photometry has emerged as a faster alternative. It works by landing individual capsids on a glass surface and measuring the light scattering from each particle, which correlates with its mass. Full and empty capsids produce distinct mass peaks, and partially filled capsids appear as a broad, heterogeneous population in between. Measurements run in triplicate have shown coefficients of variation below 8% for the percentage of each population.8Molecular Therapy Nucleic Acids. Mass photometry as a robust method for characterizing adeno-associated virus critical quality attributes in gene therapy vector Because mass photometry counts particles one at a time, it also yields the molecular weight of the empty and full capsids and can estimate the mass of the encapsulated DNA, all from a few microliters of sample in minutes.9PubMed Central. Quantification of Empty, Partially Filled and Full Adeno-Associated Virus Vectors Using Mass Photometry
Anion-exchange chromatography (AEX) offers yet another route. Because the DNA inside a full capsid contributes additional negative charge, full and empty capsids elute at different salt concentrations. An optimized AEX-HPLC method achieved baseline separation of AAV6 full and empty peaks with resolution well above 2.0, and the quantified percentages agreed closely with AUC results.10Molecular Therapy Methods & Clinical Development. Development of a Discontinuous Anion-Exchange Chromatography Method for High-Resolution Analytical Separation and Quantitation of Empty and Full AAV Capsids Newer variations using choline-based salts have improved reproducibility and reduced hazardous reagent use.11Analytical Biochemistry. Separation of full and empty adeno-associated virus capsids by anion-exchange chromatography using choline-type salts AEX runs on standard HPLC equipment that most quality-control labs already own, making it more accessible than AUC for routine testing.12PubMed Central. Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2
Capsid Protein Identity and Post-Translational Modifications
An AAV capsid is assembled from three viral proteins, VP1, VP2, and VP3, in a roughly 1:1:10 ratio. Shifts in this ratio can alter how the vector enters cells and delivers its payload, so confirming the stoichiometry is a routine check. Capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) can determine VP ratios across a range of concentrations with relative standard deviations below 7% for each protein species.13PubMed Central. Determination of AAV Capsid Protein Ratios by Sodium Dodecyl Sulfate Capillary Electrophoresis (CE‐SDS)—UV Absorption Method Capillary electrophoresis-western assays extend this by using antibodies to quantify both VP stoichiometry and residual impurities such as GP64, a baculovirus protein that can carry over when insect-cell production systems are used.14Molecular Therapy. Assessment of adeno-associated virus purity by capillary electrophoresis-based western
Beyond knowing the ratio, manufacturers need to understand what chemical modifications sit on those proteins. Capsid proteins can pick up acetylation, deamidation, oxidation, and other post-translational modifications during production and storage. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) after enzymatic digestion maps these modifications at the peptide level. Early work used SDS-PAGE gel bands digested with multiple enzymes to achieve complete sequence confirmation of AAV2 capsid proteins and revealed acetylation on the N-termini of VP1 and VP3.15PubMed. Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins More recent protocols have streamlined the process. A single-protease digestion with pepsin, for instance, can provide sequence coverage and quantitative modification data for AAV5 capsids quickly enough to keep up with manufacturing timelines.16PubMed. Fast and efficient digestion of adeno associated virus (AAV) capsid proteins for liquid chromatography mass spectrometry (LC-MS) based peptide mapping and post translational modification analysis (PTMs) Comprehensive studies across AAV serotypes 1 through rh10 have cataloged these modifications and shown that some are serotype-specific.17PubMed Central. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes
Particle Size, Aggregation, and Structural Imaging
Individual AAV particles are around 25 to 30 nanometers in diameter, but aggregation during processing or storage can produce clusters many times that size. Size-exclusion chromatography paired with multi-angle light scattering (SEC-MALS) is the workhorse for this measurement. It separates monomers from dimers, trimers, and larger aggregates while simultaneously measuring the molar mass and radius of each eluting species.18PubMed Central. Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus In one study, the monomer peak of AAV measured about 4.2 megadaltons with a root-mean-square radius of 11 to 13 nanometers, while high-molecular-weight aggregates ranged from roughly 8 to 100 megadaltons.19PubMed Central. Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus – Section: Measurement of absolute molar mass (MDa) and root-mean-square radius (nm) of rAAV by SEC-UV-RI-MALS SEC-MALS can also differentiate full and empty monomers by calculating the protein and DNA mass contributions in each peak using a protein-conjugate analysis feature.20Scientific Reports. Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering
Dynamic light scattering (DLS) provides a complementary, rapid readout. It measures how particles scatter a laser beam and calculates their hydrodynamic diameter from how quickly the scattered light fluctuates. A study evaluating DLS and multi-angle DLS on AAV5 samples measured full capsids at about 27 nanometers and empty capsids at about 33 nanometers, a size difference attributed to the slightly expanded shape of the empty shell.21PubMed Central. Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
For atomic-level structural detail, cryo-electron microscopy (cryo-EM) is unmatched. Single-particle cryo-EM has resolved the AAV2 capsid to approximately 1.86-angstrom resolution, fine enough to see individual amino acid side chains and water molecules bound to the protein shell.22Nature Communications. Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant This level of detail matters for engineering new capsid variants: researchers studying a brain-targeted variant called AAVv66 used cryo-EM at 2.5-angstrom resolution to map the structural differences responsible for its altered tissue preference.23Nature Communications. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties Cryo-EM is too slow and expensive for routine batch testing, but it informs the design of the vectors that eventually get manufactured at scale.
Genome Integrity and Packaging Fidelity
Knowing how many genomes are in a batch is not the same as knowing whether those genomes are intact. AAV has a packaging limit of about 4.7 to 5.0 kilobases. Push beyond that and the proportion of full-length genomes drops sharply. Nanopore long-read sequencing can read individual encapsidated DNA molecules from end to end, revealing truncation patterns that short-read methods would miss. One study found that the proportion of full-length genomes remained high up to 4.8 kilobases but declined rapidly between 4.9 and 5.0 kilobases, driven mainly by packaging defects rather than errors in DNA synthesis.24PubMed Central. Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing The truncation pattern was not random: the 3-prime end of the transgene cassette was preferentially retained, and the specific arrangement of genome components influenced which fragments ended up packaged.25Molecular Therapy Methods & Clinical Development. Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
Charge detection mass spectrometry (CDMS) can measure genome mass directly without extracting the DNA from the capsid first. By intentionally dissociating full particles inside the mass spectrometer, one group observed a released genome peak at 820.7 kilodaltons for an AAV8 vector with a 2,712-base genome, within about 2.4% of the theoretical value.26PubMed Central. Multimass Analysis of Adeno-Associated Virus Vectors by Orbitrap-Based Charge Detection Mass Spectrometry The same approach resolved empty, partially filled, and full populations based on their total mass, and a coupled size-exclusion chromatography step first removed aggregates and free DNA to clean up the measurement.27PubMed Central. Characterizing the Content and Structure of AAV Capsids by Size Exclusion Chromatography and Orbitrap-Based Charge Detection-Mass Spectrometry
Detecting Residual Host Cell Impurities
AAV vectors are produced inside living cells, whether human embryonic kidney cells, insect cells, or other platforms, and traces of the host’s own DNA and proteins inevitably end up in the final product. These impurities can affect safety: residual host cell DNA could theoretically carry oncogenes, and host cell proteins can provoke immune responses or degrade the product over time.
For DNA contaminants, next-generation sequencing offers an unbiased survey. A method called SSV-Seq (single-stranded DNA virus sequencing) identifies and quantifies every DNA species in a vector lot without requiring prior knowledge of what to look for, unlike qPCR which can only find sequences you already have primers for.28PubMed. Single-Stranded DNA Virus Sequencing (SSV-Seq) for Characterization of Residual DNA and AAV Vector Genomes One study of a clinical-grade AAV8 preparation found that while 87% of sequencing reads mapped to the therapeutic cassette, 13% mapped to other producer-plasmid sequences, with 4% tracing to the plasmid carrying the viral packaging genes.29Molecular Therapy Methods & Clinical Development. P5 Promoter-Associated DNA Contaminants in Recombinant Adeno-Associated Virus Vector Preparations Are Transcribed, Translated, and Immunogenic Those contaminant sequences were not biologically inert: the same study showed they could be transcribed, translated, and recognized by the immune system.
For protein contaminants, mass spectrometry-based proteomics is the emerging standard. The challenge is that AAV capsid proteins vastly outnumber host cell proteins in a purified sample, making the low-abundance impurities hard to detect. A technique called native digestion gets around this by gently digesting the sample under conditions that leave the intact AAV capsids largely undigested while breaking down the exposed host cell proteins. This approach was shown to be more effective than conventional denaturing digestion for pulling host cell proteins out of the background signal of different AAV serotypes.30PubMed. Native Digestion and Shotgun Proteomics for Host Cell Protein Profiling of Adeno-Associated Viruses Other differential digestion strategies have been developed to achieve similar sensitivity gains.31PubMed. A simple and sensitive differential digestion method to analyze adeno-associated virus residual host cell proteins by LC-MS
Thermal Stability and Capsid Charge Profiling
Different AAV serotypes unfold at different temperatures, and this melting temperature turns out to be distinctive enough to serve as an identity test. Differential scanning fluorimetry (DSF) heats a sample gradually while monitoring fluorescence changes that indicate protein unfolding. A study of AAV serotypes 1 through 9 and rh10 showed that each had a characteristic melting temperature that could distinguish it from the others, using only about 25 microliters of material at modest concentrations.32PubMed Central. Thermal Stability as a Determinant of AAV Serotype Identity A dye-free version that relies on the capsid’s own intrinsic fluorescence has since been validated as an equally accurate alternative.33PubMed. Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of Adeno-Associated Virus Serotypes One limitation is that DSF gives a single global readout for the whole sample; it cannot distinguish the stability of full capsids from empty ones in a mixture.34PubMed. Stability and Dissociation of Adeno-Associated Viral Capsids by Variable Temperature-Charge Detection-Mass Spectrometry
Capsid charge heterogeneity is another attribute that reveals the modification state of the surface. Imaged capillary isoelectric focusing (icIEF) separates capsid populations by their isoelectric point, the pH at which they carry no net charge. Each AAV serotype generates a distinctive charge profile, useful for both identity confirmation and stability monitoring.35PubMed. Imaged Capillary Isoelectric Focusing (icIEF) Platform for Characterization of Charge Variants of Adeno-Associated Virus (AAV) Capsids and Impact on their Transduction Efficiency The technique can detect chemical changes like deamidation and oxidation that accumulate during storage.36Green Analytical Chemistry. Establishment of a platform imaged capillary isoelectric focusing (icIEF) characterization method for adeno-associated virus (AAV) capsid proteins Recent work using icIEF immunoassays that specifically isolate VP3 has confirmed that deamidation of VP3 is a key driver of the acidic charge variants seen in AAV9 preparations.37PubMed Central. Insights into Adeno-Associated Virus Capsid Charge Heterogeneity
Potency and Functional Assays
All the physical and chemical measurements described so far tell you what is in the vial. Potency assays tell you whether it actually works. The distinction matters because a vector can look fine on every analytical metric and still be functionally dead if the capsid has been subtly damaged in a way that prevents cell entry or gene expression.
Functional titer assays measure how many particles in a batch can actually transduce cells and express the transgene. A comparison of different approaches found that only methods measuring biological activity, such as vector genome replication or transgene expression, could accurately distinguish infectious from non-infectious particles, while methods that simply counted how many genomes entered cells could not.38PubMed Central. Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls This is an important distinction: genome uptake alone does not prove the vector has done its job.
Traditional infectious titer assays require coinfection with a helper virus like adenovirus, which adds variability and complexity. Newer engineered cell lines have been designed to bypass this. One approach integrates the necessary helper-virus genes under inducible promoters directly into the assay cells, eliminating the need for live adenovirus.39PubMed Central. Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors Another group developed a cell line with increased susceptibility to diverse AAV serotypes and used it to show that genome titer remained stable when AAV9 was exposed to elevated temperatures, but functional titer dropped sharply at 42 degrees Celsius, a loss that genome-counting methods completely missed.40Molecular Therapy Methods & Clinical Development. Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable in vitro potency assays That experiment is a clean illustration of why potency testing is not optional: a batch that passes every physical characterization test can still fail the one that matters most.
Why Orthogonal Methods Matter
Each technique described above has blind spots. AUC resolves partial capsids better than AEX, but AEX runs faster on standard lab equipment. Mass photometry is rapid but does not distinguish partially filled species as cleanly as multiwavelength AUC. Genome titer tells you how much DNA is in the vial but says nothing about whether the capsid around it is functional. Cryo-EM gives exquisite structural detail but cannot be run on every production lot. The field has settled on a strategy of layering multiple methods, each validating or extending what the others reveal. A mature characterization panel for a clinical AAV vector might include ddPCR for genome titer, AUC or AEX for full-to-empty ratio, SEC-MALS for aggregation, CE-SDS or LC-MS for capsid protein composition, DSF or icIEF for identity and stability, next-generation sequencing for genome integrity and residual DNA, mass spectrometry-based proteomics for host cell proteins, and a cell-based transduction assay for potency. Each method answers a question the others cannot, and together they produce the kind of multidimensional quality picture that regulators expect before a gene therapy can be dosed in patients.